• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本单中心急性脓胸的15年观察队列研究。

A 15-Year Observational Cohort of Acute Empyema at a Single-Center in Japan.

作者信息

Asai Nobuhiro, Ohashi Wataru, Shibata Yuichi, Sakanashi Daisuke, Kato Hideo, Hagihara Mao, Suematsu Hiroyuki, Mikamo Hiroshige

机构信息

Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan.

Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan.

出版信息

Antibiotics (Basel). 2024 Dec 11;13(12):1205. doi: 10.3390/antibiotics13121205.

DOI:10.3390/antibiotics13121205
PMID:39766595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11672654/
Abstract

Despite the advancements in diagnostic methods and antibiotic treatment, empyema is a critical respiratory infection, showing a high mortality rate of 10-25%. To evaluate the bacterial etiology and prognostic factors of acute empyema, we conducted this long-term retrospective cohort study at our institute between 2008 and 2022. A total of 80 patients were enrolled in this cohort. The median age was 72 years (range 19 to 93 years), and 61 (76%) were male. The most common underlying disease was malignancy, seen in 28 (35%). The mean Charlson comorbidity index (CCI) was 2.7 (±2.4). The 30-day and in-hospital mortality were 9 (11%) and 15 (19%), respectively. Univariate analysis revealed that healthcare-associated infection, inappropriate treatment, high CCI score, performance status (PS) of 2-4, and isolation of potentially drug-resistant (PDR) pathogens were poor prognostic factors. Finally, multivariate analysis showed that high CCI score ( = 0.009) and isolation of PDR pathogens ( = 0.011) were independent poor prognostic factors for in-hospital death in acute empyema. We found that higher CCI scores and isolation of PDR pathogens were independent poor prognostic factors for in-hospital mortality among empyema patients.

摘要

尽管诊断方法和抗生素治疗取得了进展,但脓胸仍是一种严重的呼吸道感染,死亡率高达10%-25%。为了评估急性脓胸的细菌病因和预后因素,我们于2008年至2022年在我院开展了这项长期回顾性队列研究。该队列共纳入80例患者。中位年龄为72岁(范围19至93岁),61例(76%)为男性。最常见的基础疾病是恶性肿瘤,共28例(35%)。Charlson合并症指数(CCI)的平均值为2.7(±2.4)。30天和住院死亡率分别为9例(11%)和15例(19%)。单因素分析显示,医疗相关感染、治疗不当、CCI评分高、2-4级的体能状态(PS)以及分离出潜在耐药(PDR)病原体是不良预后因素。最后,多因素分析表明,CCI评分高( = 0.009)和分离出PDR病原体( = 0.011)是急性脓胸患者住院死亡的独立不良预后因素。我们发现,较高的CCI评分和分离出PDR病原体是脓胸患者住院死亡率的独立不良预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab75/11672654/5ecec79ed1fa/antibiotics-13-01205-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab75/11672654/7efd4117b2ba/antibiotics-13-01205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab75/11672654/5ecec79ed1fa/antibiotics-13-01205-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab75/11672654/7efd4117b2ba/antibiotics-13-01205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab75/11672654/5ecec79ed1fa/antibiotics-13-01205-g002.jpg

相似文献

1
A 15-Year Observational Cohort of Acute Empyema at a Single-Center in Japan.日本单中心急性脓胸的15年观察队列研究。
Antibiotics (Basel). 2024 Dec 11;13(12):1205. doi: 10.3390/antibiotics13121205.
2
Could quick SOFA and SOFA score be a predictive tool for 30-day and in-hospital mortality in acute empyema?快速 SOFA 评分和 SOFA 评分能否成为急性脓胸 30 天和住院死亡率的预测工具?
J Infect Chemother. 2022 Dec;28(12):1687-1692. doi: 10.1016/j.jiac.2022.08.001. Epub 2022 Aug 7.
3
The etiology and bacteriology of healthcare-associated empyema are quite different from those of community-acquired empyema.医疗保健相关脓胸的病因学和细菌学与社区获得性脓胸的病因学和细菌学有很大不同。
J Infect Chemother. 2017 Oct;23(10):661-667. doi: 10.1016/j.jiac.2017.04.011. Epub 2017 Jul 24.
4
Combination of Sequential Organ Failure Assessment (SOFA) score and Charlson Comorbidity Index (CCI) could predict the severity and prognosis of candidemia more accurately than the Acute Physiology, Age, Chronic Health Evaluation II (APACHE II) score.序贯器官衰竭评估(SOFA)评分与 Charlson 合并症指数(CCI)的联合应用,较急性生理学与慢性健康状况评分系统 II(APACHE II)评分能更准确地预测念珠菌血症的严重程度和预后。
BMC Infect Dis. 2021 Jan 15;21(1):77. doi: 10.1186/s12879-020-05719-8.
5
Clinical characteristics and decortication outcomes of bacterial, tuberculous and fungal pleural infection.细菌性、结核性和真菌性胸膜感染的临床特征和剥脱术治疗结果。
Int J Tuberc Lung Dis. 2024 Nov 1;28(11):541-546. doi: 10.5588/ijtld.24.0146.
6
An independent prognostic factor in surgical cases of pleural empyema caused by common bacteria is the presence of a fistula.由常见细菌引起的胸膜脓胸手术病例中的一个独立预后因素是存在瘘管。
Gen Thorac Cardiovasc Surg. 2023 Nov;71(11):657-664. doi: 10.1007/s11748-023-01933-8. Epub 2023 Mar 31.
7
Fungal empyema thoracis: an emerging clinical entity.真菌性脓胸:一种新出现的临床实体。
Chest. 2000 Jun;117(6):1672-8. doi: 10.1378/chest.117.6.1672.
8
Choice of first intervention is related to outcomes in the management of empyema.首次干预措施的选择与脓胸管理的结局相关。
Ann Thorac Surg. 2009 May;87(5):1525-30; discussion 1530-1. doi: 10.1016/j.athoracsur.2009.01.028.
9
[Risk factors associated with long-term mortality in patients with pulmonary embolism and the predictive value of Charlson comorbidity index].[肺栓塞患者长期死亡率的相关危险因素及查尔森合并症指数的预测价值]
Zhonghua Yi Xue Za Zhi. 2016 Jan 26;96(4):273-6. doi: 10.3760/cma.j.issn.0376-2491.2016.04.009.
10
[Risk factors associated with mortality in patient with non-high-risk pulmonary embolism and cancer and the prognostic value of Charlson comorbidity index].[非高危肺栓塞合并癌症患者的死亡相关危险因素及查尔森合并症指数的预后价值]
Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2383-2387. doi: 10.3760/cma.j.cn112137-20200427-01343.

引用本文的文献

1
Pleural Empyema in Spain (2016-2022): A Nationwide Study on Trends in Hospitalizations, Mortality, and Impact of Comorbidities.西班牙的胸膜脓胸(2016 - 2022年):一项关于住院治疗趋势、死亡率及合并症影响的全国性研究
J Pers Med. 2025 Jun 20;15(7):263. doi: 10.3390/jpm15070263.

本文引用的文献

1
Microbiome modifications by steroids during viral exacerbation of asthma and in healthy mice.类固醇在哮喘病毒加重期和健康小鼠中对微生物组的修饰作用。
Am J Physiol Lung Cell Mol Physiol. 2024 Nov 1;327(5):L646-L660. doi: 10.1152/ajplung.00040.2024. Epub 2024 Aug 19.
2
What prognostic factors have impacted the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic oral cancer?哪些预后因素影响了复发性或转移性口腔癌患者免疫检查点抑制剂的疗效?
J Stomatol Oral Maxillofac Surg. 2024 Sep;125(4S):101961. doi: 10.1016/j.jormas.2024.101961. Epub 2024 Jul 1.
3
Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data.
免疫检查点抑制剂治疗的癌症患者的伴随用药对临床结局的影响:基于健康保险审查与评估数据的分析。
J Cancer Res Clin Oncol. 2024 Apr 10;150(4):186. doi: 10.1007/s00432-024-05728-z.
4
The outcomes of thoracoscopic decortication between fungal empyema and bacterial empyema.胸腔镜下肺切除治疗真菌性脓胸和细菌性脓胸的疗效比较。
BMC Infect Dis. 2023 Jan 6;23(1):8. doi: 10.1186/s12879-022-07978-z.
5
Could quick SOFA and SOFA score be a predictive tool for 30-day and in-hospital mortality in acute empyema?快速 SOFA 评分和 SOFA 评分能否成为急性脓胸 30 天和住院死亡率的预测工具?
J Infect Chemother. 2022 Dec;28(12):1687-1692. doi: 10.1016/j.jiac.2022.08.001. Epub 2022 Aug 7.
6
The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy.新型冠状病毒肺炎的病理生理学机制和宿主免疫,重点探讨肺部和肠道微生物组失调以及妊娠的相关问题。
Respir Investig. 2022 Jul;60(4):496-502. doi: 10.1016/j.resinv.2022.03.002. Epub 2022 Apr 4.
7
Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study.从一项多国研究中通过宏基因组学鉴定预测胰腺癌的微生物特征。
Gastroenterology. 2022 Jul;163(1):222-238. doi: 10.1053/j.gastro.2022.03.054. Epub 2022 Apr 8.
8
Diagnostic Accuracy of Imaging Findings in Pleural Empyema: Systematic Review and Meta-Analysis.胸膜腔积脓影像学表现的诊断准确性:系统评价与荟萃分析
J Imaging. 2021 Dec 28;8(1):3. doi: 10.3390/jimaging8010003.
9
Pediatric Parapneumonic Effusion/Pleural Empyema in Japan: A Nationwide Survey.日本小儿脓胸/脓性胸腔积液:一项全国性调查。
Pediatr Infect Dis J. 2022 Jan 1;41(1):20-23. doi: 10.1097/INF.0000000000003353.
10
The Lung Microbiome during Health and Disease.肺部微生物组在健康和疾病中的作用
Int J Mol Sci. 2021 Oct 8;22(19):10872. doi: 10.3390/ijms221910872.